Journals / Journal of Ankara Medical School / 2002 / Cilt: 24 - Sayı: 3

Koroner bypasstakarnitinin kan kardiyoplejisinde kullanımı

Usage of carnitine in blood cardioplegia in coronary artery bypass grafting

Pages
119–127
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Although there was no significant difference between three groups in hospital mortality and morbidity, blood with carnitine provides better myocardial protection and recovery from ischemia than do crystalloid cardioplegia and blood cardioplegia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: This study is performed to compare crystalloid, blood and carnitine blood cardioplegias (CP) in elective coronary artery bypass grafting.
📊
Key Findings & Data:Methods: Forty-five patients were randomized to three technique of myocardial protection (15 patients in each): Group I cold crystalloid CP, Group II tepid blood CP, Group III tepid blood CP with 5mM/L of carnitine.
💡
Conclusion & Impact:Conclusions: Although there was no significant difference between three groups in hospital mortality and morbidity, blood with carnitine provides better myocardial protection and recovery from ischemia than do crystalloid cardioplegia and blood cardioplegia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: This study is performed to compare crystalloid, blood and carnitine blood cardioplegias (CP) in elective coronary artery bypass grafting. Methods: Forty-five patients were randomized to three technique of myocardial protection (15 patients in each): Group I cold crystalloid CP, Group II tepid blood CP, Group III tepid blood CP with 5mM/L of carnitine. Blood samples taken from coronary sinus and arterial blood were collected in preoperative and postoperative period (6, 12, 24, and 48 postoperative hours) for enzyme measurements. Also hemodynamic parameters were measured at same time periods. Results: All the patients involved completed the study. Hemodynamic parameters in all groups were similar. Also neither preoperative nor postoperative myocardial infarction was observed in any group. CKMB and c Tn-l levels were elevated in all three groups after cross clamping until 6th hour and 12th hour for LDH all three groups. In all enzyme measurements, especially in cTn-I, decline in enzyme levels started earlier in BCCP group than other two groups. Conclusions: Although there was no significant difference between three groups in hospital mortality and morbidity, blood with carnitine provides better myocardial protection and recovery from ischemia than do crystalloid cardioplegia and blood cardioplegia.

Özet

Amaç: Bu çalışma kristaloid, kan ve karnitin kardiyoplejilerinin elektif koroner baypas cerrahisinde miyokard korunması üzerine etkilerini araştırmak üzere planlandı. Metod: 45 hasta her grupta 15er hasta olacak şekilde randomize olarak 3 gruba ayrıldı: Grup I'te kristaloid kardiyoplejisi, Grup II'de kan kardiyoplejisi, Grup III'de de içinde 5mM/L karnitin bulunan kan kardiyoplejijsi kullanıldı. Enzim çalışmaları için koroner sinus ve arteryal hattan preoperatif ve post operatif (6., 12., 24., ve 48. saatlerde) kan örnekleri alındı. Yine aynı zaman dilimlerinde hemodinamik parametreler ölçüldü. Sonuç: Bütün gruplardaki hastalar çalışmayı tamamladı. Hemodinamik parametreler üç grupta benzerdi. Yine hiçbir hastada peri ve postoperatif dönemde miyokard enfarktüsü gözlenmedi. Her üç grupta da CK-MB ve cTn-I seviyeleri krossklempten itibaren 6. saate kadar, LDH'da ise 12. saate kadar yüksek kaldı. Bütün enzimlerde özelliklede cTn-I daki düşme karnitin grubunda diğer gruplardan önce başladı. Tartışma: Her nekadar üç grup arasında hastane morbiditesi ve mortalitesi açısından anlamlı fark yoksa da, karnitin kardiyoplejisi kristaloid ve tek başına kan kardiyoplejisine nazaran daha iyi miyokard koruması sağlamakla beraber reperfüzyon hasarını en aza indirmektedir.

🔖

Cite This Article

EREN, N. T. (2022). Koroner bypasstakarnitinin kan kardiyoplejisinde kullanımı. Journal of Ankara Medical School, Cilt: 24 - Sayı: 3, 119–127. https://ajindex.com/articles/559940

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Vaage J, Valen G: Pathophysiology and mediators of ischemia-reperfusion injury with special referen¬ ce to cardiac surgery. Scand J Thor Cardiovasc Surg 1993;41:M8 i 2. Pichon H, Chocron S, Alwan K, Toubin G, et al: Crystalloid Versus Cold Blood Cardioplegia and Cardiac Troponin I Release. Circulation 1997;96:316-320 3. Horvath KA, Parker MA, Frederikson JW, Palmer AS, Fullerton DA: Postoperative Troponin I Values: Insult or Injury?. Clin. Cardiol. 2000;23:731-733 4. Chocron S, Alwan K, Toubin G, Clement F, et al: Crystalloid Cardioplegia Route of Delivery and Cardiac Troponin I Release. Ann Thorac Surg 1996;62:481-485 5.Codd JE, Barner HB, Pennington DG, et al: Intraope-rative Myocardial Protection: A Comparison of blo¬od and asanguineous cardioplegia. Ann Thorac Surg1985;39:2;125-133 6. Metzler H, Gries M, Rehak P, et al: Perioperative myocardial cell injury:the role of troponins. British Journal of Anaesthesia 1997; 78: 386-390 7. Bremer D: Carnitine metabolism and function. Physiol Rev 1983;63:421-480 8. Neeley JR, Morgan HE: Relationship between car- bohydrate and lipid metabolism and the energy ba¬lance of heart muscle: Annu Rev Physiol 1974;36:413-454 9. Vary TC, Neeley JR: A mechanism for reduced myo- cardial carnitine levels in diabetic animals. Am J Physiol 1982;243:154-158 10. Feuvray D, Idell-Wenger JA, Neeley JR: Effects of ischemia on rat myocardial function and metabo¬ lism in diabetes. Circ Res 1979;44:322-329 11. Spagnoli LG, Corsi M, Villaschi S, et al: Myocardi¬ al carnitine deficiency in acute myocardial infarcti¬ on: Lancet 1982;1:1419-1420 12. Shug AL: Changes in tissue levels of carnitine du¬ ring myocardial ischemia and anoxia: Arch Bioc- hem Biophys 1978;87:25-33 13. Regitz V, Shug AL,,Fleck E: Defective myocardial carnitine metabolism in CHF secondary to dilated cardiomyopathy: Am J Cardiol 1990;65:755-760 14. Bressler R, Gray R, Copeland JG, et al: Chronic in¬ hibition of fatty acid oxidation: new model of dias- tolic dysfunction. Life Sci 1989;44::1897-1906 15. Gay WA Jr, Ebert PA. Functional, metabolic and morphologic effects of potassium-induced cardiop¬ legia. Surgery.1973;74:284-290 16. Barner HB. Blood cardioplegia: a review andcom- parison with crystalloid cardioplegia. Ann Thorac Surg. 1991;52:1354-1367 17. Fremes SE, Christakis GT, Weisel RD, et al. A clini¬ cal trial of blood and crystalloid cardioplegia. J Thorac Cardiovasc Surg. 1984;88:726-741 18. Julia PL, Buckberg GD, Acar C, Prtington MT, Sher¬ man MP. Studie